Evidence map›Paper›PMID 37212379›Full record

ReviewCancer control : journal of the Moffitt Cancer Center

Research Progress of Multiple Primary Malignancies Associated With Esophageal Cancer.

Yu Cui, Wenxia Ren, Xue Du, Lu Yang, Bangxian Tan

Open access · goldAbstract readReview
In one paragraph

Review in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Esophageal cancer: A global challenge requiring tailored strategies.World journal of gastrointestinal oncology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yu CuiDepartment of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong City, Sichuan Province, China.ORCID 0000-0002-4970-9980
Wenxia RenDepartment of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong City, Sichuan Province, China.
Xue DuDepartment of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong City, Sichuan Province, China.
Lu YangDepartment of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong City, Sichuan Province, China.
Bangxian TanDepartment of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong City, Sichuan Province, China.
Affiliated Hospital of North Sichuan Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the improvement in survival of patients with tumors, and continuous advancement of diagnostic technology and treatment modalities, instances of multiple primary malignancies (MPMs) are becoming an increasingly common phenomenon. The occurrence of esophageal-relevant MPMs increases the difficulty of diagnosis and treatment, and the overall prognosis is poor. Esophageal cancer related-MPMs tend to occur in areas such as the head, neck, stomach, and lungs. "Field cancerization" is one theoretical basis for the disease, and chemoradiotherapy, environmental life factors, and gene polymorphism are etiological factors. However, the influence of new therapeutic methods on MPM is still unclear, and the relationship between gene polymorphism and MPMs related to esophageal cancer needs further elucidation. Additionally, there is a lack of unified standards for diagnosis and treatment. Therefore, this study aimed to review the causes, clinical features, and prognostic factors of MPMs related to esophageal cancer.

Indexed as

Esophageal NeoplasmsNeoplasms, Multiple PrimaryHumansPrognosisepidemiologyesophageal carcinomaetiologymultiple primary malignanciesprognosis

Identifiers

PMID37212379
PMCPMC10214099
OpenAlexW4377220818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.